APA (7th ed.) Citation

Zhixuan Wu, Haoyi Xiang, Xiaowu Wang, Rongrong Zhang, Yangyang Guo, Liangchen Qu, . . . Yanyi Xiao. (2024). Integrating network pharmacology, molecular docking and experimental verification to explore the therapeutic effect and potential mechanism of nomilin against triple-negative breast cancer. BMC.

Chicago Style (17th ed.) Citation

Zhixuan Wu, Haoyi Xiang, Xiaowu Wang, Rongrong Zhang, Yangyang Guo, Liangchen Qu, Jingyao Zhou, and Yanyi Xiao. Integrating Network Pharmacology, Molecular Docking and Experimental Verification to Explore the Therapeutic Effect and Potential Mechanism of Nomilin Against Triple-negative Breast Cancer. BMC, 2024.

MLA (9th ed.) Citation

Zhixuan Wu, et al. Integrating Network Pharmacology, Molecular Docking and Experimental Verification to Explore the Therapeutic Effect and Potential Mechanism of Nomilin Against Triple-negative Breast Cancer. BMC, 2024.